
Last week, the US government voted to impose a blanket ban on all so-called ‘intoxicating hemp’ substances, ending what has

Germany’s medical cannabis imports continued their historic run in Q3 of 2025, seeing the country bring in just under 57

The long-running battle over the future of the US hemp industry has become an unlikely flashpoint in efforts to end

From the euphoric highs of 2018’s ‘green rush’ to the sharp corrections and structural stasis that have followed, cannabis equities

Despite being the second-largest and one of the most mature medical cannabis markets in Europe, the UK still falls well

Germany’s telemedicine-fuelled expansion has driven the value of its medical cannabis market up by hundreds of millions of euros in

The medical cannabis industries in Australia and New Zealand are continuing to evolve rapidly, with both markets showing signs of

Since Germany’s Cannabis Act (CanG) came into force on 1 April 2024, much has changed regarding what was once the

The UK’s cannabis industry, one of the largest on the planet, sits at a crossroads. Does it choose the pharmaceutically

Switzerland’s draft cannabis plan proposes a single online retailer, raising opportunities and risks as it pursues Europe’s first adult-use market.
We won’t spam you
© 2024 Prohibition Holdings Ltd. All Rights Reserved.
© 2023 Prohibition Holdings Ltd. All Rights Reserved.